Key Takeaways
HRT conversations have changed over time.
Dr. Green discusses how the Women's Health Initiative shaped fear and confusion around hormone replacement therapy for both patients and physicians. He explains that HRT conversations should be more nuanced than a simple yes-or-no answer, with treatment decisions based on symptoms, health history, age, risk factors, and physician review.
Symptoms can be more subtle than hot flashes.
The episode highlights that many women wait for hot flashes before considering whether other changes may be related to menopause or perimenopause. Dr. Green discusses sleep disruption, weight changes, hair thinning, mood changes, brain fog, and joint discomfort as examples of symptoms that can gradually build over time.
Treatment options should be individualized.
Dr. Green explains that menopause care should not be one-size-fits-all. In the episode, he discusses estrogen, progesterone, DHEA, and different delivery formats, including pills, creams, and patches, while emphasizing that the best approach depends on a woman's health history, risk factors, treatment goals, and physician review.
Progesterone may be part of HRT for women with a uterus.
The episode covers why progesterone is usually included in hormone therapy for women who still have a uterus. Treatment decisions depend on a woman's symptoms, health history, risk factors, treatment goals, and physician review.
Telehealth can make menopause care more accessible.
Dr. Green explains how Winona's telehealth process helps women share symptoms, answer health questions, review treatment preferences, and receive physician-reviewed treatment options. He also notes that telehealth has limits and may not be the right setting for every medical history or concern.